The Clinical Outcome of Prospective Screening for Multiple Endocrine Neoplasia Type 2A
Robert F. Gagel(The University of Texas MD Anderson Cancer Center), Seymour Reichlin, A H Tashjian, T.S. Cummings, Hubert J. Wolfe(Boston University), N. PAPATHANASOPOULOS, Ronald A. DeLellis
Cited by 330
Related Papers
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
|Journal of Clinical Oncology|2010|517
C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma
|New England Journal of Medicine|1973|452
Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization.
|Journal of Bone and Joint Surgery|1993|437